Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

The FDA has approved Yeztugo for PrEP to reduce the risk of sexually acquired HIV-1 in adults and adolescents weighing at least 35kg.

The Food and Drug Administration (FDA) has approved Harliku ™ (nitisinone) for the reduction of urine homogentisic acid (HGA) in adult patients with alkaptonuria.

Supplements, when approved by your doctor, may help you meet your nutritional needs. But there are potential health risks to ...

MORE medicines for cancer, diabetes, high cholesterol, hypertension, tuberculosis and mental diseases have been exempted from 12-percent value-added tax (VAT) by the Bureau of Internal Revenue (BIR).

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...

Ever wish that you could make your dog's life longer? While crossing the rainbow bridge is part of a dog's short life, ...

LIKMEZTM (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals s ...

Viking Therapeutics initiates VANQUISH phase 3 obesity clinical programme with GLP-1/GIP agonist VK2735: San Diego Thursday, June 26, 2025, 10:00 Hrs [IST] Viking Therapeutics, In ...

Phathom gains FDA exclusivity for VOQUEZNA through 2032, boosting stock. DCF values shares at $14 with 43% upside potential.

Taking one peptide supplement at a time could help improve muscle growth, but experts warn against stacking multiple at the ...